Championing Diversity and Inclusion in Clinical Trials
- Admin
- Dec 3
- 1 min read
At Phortas, we are committed to advancing patient-centric and globally relevant drug development.
We’re pleased to announce that on 11 December 2025 at 13:00 CET, Dr. Darius-Jean Namdjou, will present on a topic of increasing importance for our industry: the need for greater diversity, inclusion, and patient representation in clinical trials. 🙂
Underrepresentation across gender, ethnicity, socioeconomic status, and other factors continues to influence the quality and applicability of clinical evidence.
Recent initiatives from the EMA, FDA, and WHO highlight a global shift toward improving equity and ensuring that clinical research reflects real-world populations.
This session will cover:
Current global efforts to foster diversity and inclusion
Evolving regulatory expectations
The importance of strengthening the patient voice in development
Learning objective:
Equipping participants with the knowledge needed to raise awareness and begin implementing more inclusive approaches in clinical development.
Level: Intermediate
📎 More details & registration:
We look forward to contributing to this vital discussion and supporting a more equitable future for clinical research.
For more information, contact us at: info@phortas.com
Comments